These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2976163)

  • 21. Myeloprotective effect of high dose medroxyprogesterone acetate (MPA).
    Wils JA
    Chemioterapia; 1988 Feb; 7(1):60-2. PubMed ID: 2967738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate: its correlation with serum cortisol.
    Van Deijk WA; Blijham GH; Mellink WA; Meulenberg PM
    Cancer Treat Rep; 1985 Jan; 69(1):85-90. PubMed ID: 3155651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [High-dose gestagen therapy with medroxyprogesterone acetate in metastasizing breast carcinoma].
    Bastert G; Michel RT
    Med Welt; 1983 Mar; 34(12):378-82. PubMed ID: 6222235
    [No Abstract]   [Full Text] [Related]  

  • 24. [Medroxyprogesterone acetate (MPA) in the treatment of advanced breast cancer].
    Izuo M
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2604-11. PubMed ID: 2956928
    [No Abstract]   [Full Text] [Related]  

  • 25. [High dose medroxyprogesterone acetate in metastatic breast cancer. Comparative clinical, pharmacokinetic and pharmacodynamic data of different forms of administration].
    Blossey HC; Wander HE; Nagel GA; Köbberling J; Kleeberg U
    Onkologie; 1982 Aug; 5 Suppl():13-6. PubMed ID: 6215599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral versus im administration of high-dose medroxyprogesterone acetate in pretreated patients with advanced breast cancer.
    Beex L; Burghouts J; van Turnhout J; Breed W; Hillen H; Holdrinet A; Boetius G; Hoogendoorn G; Doesburg W; Verhulst M
    Cancer Treat Rep; 1987 Dec; 71(12):1151-6. PubMed ID: 3690524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer.
    Pannuti F; Martoni A; Di Marco AR; Piana E; Saccani F; Becchi G; Mattioli G; Barbanti F; Marra GA; Persiani W; Cacciari L; Spagnolo F; Palenzona D; Rocchetta G
    Eur J Cancer (1965); 1979 Apr; 15(4):593-601. PubMed ID: 86447
    [No Abstract]   [Full Text] [Related]  

  • 28. [Medroxyprogesterone acetate (MAP) in high doses in the treatment of breast cancer in advanced stages].
    Pannuti F; Di Marco AR; Martoni A; Fruet F; Strocchi E; Burroni P; Marraro D
    Minerva Ginecol; 1982 Nov; 34(11):977-9. PubMed ID: 7155427
    [No Abstract]   [Full Text] [Related]  

  • 29. ACTH and cortisol plasma levels in cancer patients treated with medroxyprogesterone acetate at high dosages.
    Papaleo C; Carella C; Zito GA; Figlia A; Capuano F; Amato G
    Chemioterapia; 1984 Aug; 3(4):220-2. PubMed ID: 6099752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose medroxyprogesterone acetate in advanced breast cancer. Clinical and pharmacokinetic study with a combined oral and intramuscular regimen.
    Becher R; Miller AA; Höffken K; Gerhold U; Hirche H; Schmidt CG
    Cancer; 1989 May; 63(10):1938-43. PubMed ID: 2522811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of large doses of medroxyprogesterone acetate (MPA) on urinary estrogen levels and serum levels of cortisol T4 LH and testosterone in patients with advanced cancer.
    Sadoff L; Lusk W
    Obstet Gynecol; 1974 Feb; 43(2):262-7. PubMed ID: 4359078
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical trial of high-dose medroxyprogesterone acetate in advanced breast cancer].
    Jiang Z; Song S; Li J
    Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):71-3. PubMed ID: 7656795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Medroxyprogesterone acetate (MAP) and aminoglutethimide (AG) in metastatic breast carcinoma. Preliminary report on a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force].
    Wander HE; Nagel GA; Blossey HC
    Onkologie; 1982 Aug; 5 Suppl():28-33. PubMed ID: 6215600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weekly low-dose doxorubicin with or without high-dose medroxyprogesterone acetate as secondary treatment in metastatic breast cancer--a randomized trial.
    Elomaa I; Blomqvist C; Rissanen P; Mäntylä M
    Acta Oncol; 1988; 27(3):297-9. PubMed ID: 2970862
    [No Abstract]   [Full Text] [Related]  

  • 35. [Oral high doses of medroxyprogesterone acetate (MPA) in the treatment of advanced phases of breast and endometrial cancer].
    Bernardo-Strada MR; Imparato E; Aspesi G; Pavesi L; Robustelli Della Cuna G
    Minerva Med; 1980 Nov; 71(44):3241-6. PubMed ID: 7454090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of high-dose medroxyprogesterone acetate (MPA) therapy in women with advanced breast cancer.
    Johnson JR; Priestman TJ; Fotherby K; Kelly KA; Priestman SG
    Br J Cancer; 1984 Sep; 50(3):363-6. PubMed ID: 6235831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status of high dose progestin treatment in advanced breast cancer.
    Mattsson W
    Breast Cancer Res Treat; 1983; 3(2):231-5. PubMed ID: 6225476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gestagen therapy of breast cancer. Effect of high doses on the blood coagulation system].
    Schenk H; Fereberger W
    MMW Munch Med Wochenschr; 1983 Oct; 125(40):875-6. PubMed ID: 6226871
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacoclinical data on high dose medroxyprogesterone acetate in advanced breast cancer.
    Namer M; Milano G; Khater R; Frenay M; Thyss A; Renée N
    Breast Cancer Res Treat; 1986; 8(2):161-3. PubMed ID: 2949788
    [No Abstract]   [Full Text] [Related]  

  • 40. Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial.
    Focan C; Beauduin M; Salamon E; de Greve J; de Wasch G; Lobelle JP; Majois F; Tagnon A; Tytgat J; van Belle S; Vandervellen R; Vindevoghel A;
    Br J Cancer; 2001 Jul; 85(1):1-8. PubMed ID: 11437394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.